Pritumumab binding to glioma cells induces ADCC and inhibits tumor growth.

Santosh Kesari,Ivan Babic,Rajesh Mukthavaram,Pengfei Jiang,Natsuko Nomura,Sandeep C. Pingle,Tiffany Juarez,Junbao Yang,Venkata Yenugonda,Elmar Nurmemmedov,Mark C. Glassy

Pritumumab binding to glioma cells induces ADCC and inhibits tumor growth.

2017

Santosh Kesari
Ivan Babic
Rajesh Mukthavaram
Pengfei Jiang
Natsuko Nomura
Sandeep C. Pingle
Tiffany Juarez
Junbao Yang
Venkata Yenugonda
Elmar Nurmemmedov
Mark C. Glassy

e14004Background: Pritumumab is a natural human IgG1 kappa antibody originally isolated from a regional draining lymph node of a patient with cervical carcinoma. This antibody binds ectodomain vime...

Keywords:

Pritumumab
Antibody-dependent cell-mediated cytotoxicity
Glioma
Cancer research
Pathology
Medicine
cervical carcinoma
Lymph node
Antibody
Ectodomain
tumor growth

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations